WO2004039952A3 - Procedes d'utilisation de polypeptides humains codes par des polynucleotides - Google Patents

Procedes d'utilisation de polypeptides humains codes par des polynucleotides Download PDF

Info

Publication number
WO2004039952A3
WO2004039952A3 PCT/US2003/033725 US0333725W WO2004039952A3 WO 2004039952 A3 WO2004039952 A3 WO 2004039952A3 US 0333725 W US0333725 W US 0333725W WO 2004039952 A3 WO2004039952 A3 WO 2004039952A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
polynucleotides
modulators
polypeptides encoded
compositions
Prior art date
Application number
PCT/US2003/033725
Other languages
English (en)
Other versions
WO2004039952A8 (fr
WO2004039952A2 (fr
Inventor
Lewis T. Williams
Keting Chu
Ernestine Lee
Kevin Hestir
Pierre Alvaro Beaurang
Dirk Behrens
Robert F. Halenbeck
Srinivas Kothakota
Haishan Lin
Thomas Linnemann
Kirsten Pierce
Yan Wang
Justine G P. Wong
Ge Wu
Hongbing Zhang
Changjiang Zeng
Original Assignee
Five Prime Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Five Prime Therapeutics, Inc. filed Critical Five Prime Therapeutics, Inc.
Priority to AU2003294236A priority Critical patent/AU2003294236A1/en
Publication of WO2004039952A2 publication Critical patent/WO2004039952A2/fr
Publication of WO2004039952A8 publication Critical patent/WO2004039952A8/fr
Publication of WO2004039952A3 publication Critical patent/WO2004039952A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des polynucléotides, des polypeptides associés, des compositions associées d'acides nucléiques et de polypeptides, et des modulateurs associés, ainsi que des anticorps et des modulateurs à petites molécules. L'invention concerne également des procédés de fabrication et d'utilisation de ces polynucléotides, polypeptides, compositions associées et modulateurs. Lesdits procédés comportent des applications diagnostiques, prophylactiques et thérapeutiques. Les compositions et procédés selon l'invention servent au traitement de maladies prolifératives, par ex. de cancers et de maladies inflammatoires, immunitaires, bactériennes et virales.
PCT/US2003/033725 2002-10-25 2003-10-24 Procedes d'utilisation de polypeptides humains codes par des polynucleotides WO2004039952A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003294236A AU2003294236A1 (en) 2002-10-25 2003-10-24 Methods of use for novel human polypeptides encoded by polynucleotides

Applications Claiming Priority (64)

Application Number Priority Date Filing Date Title
US42106102P 2002-10-25 2002-10-25
US42155202P 2002-10-25 2002-10-25
US60/421,552 2002-10-25
US60/421,061 2002-10-25
US42217702P 2002-10-30 2002-10-30
US60/422,177 2002-10-30
US42639402P 2002-11-15 2002-11-15
US42691602P 2002-11-15 2002-11-15
US42643002P 2002-11-15 2002-11-15
US60/426,430 2002-11-15
US60/426,394 2002-11-15
US60/426,916 2002-11-15
US42932602P 2002-11-27 2002-11-27
US42930202P 2002-11-27 2002-11-27
US42965102P 2002-11-27 2002-11-27
US60/429,302 2002-11-27
US60/429,326 2002-11-27
US60/429,651 2002-11-27
US43064502P 2002-12-04 2002-12-04
US43066802P 2002-12-04 2002-12-04
US43065102P 2002-12-04 2002-12-04
US60/430,645 2002-12-04
US60/430,668 2002-12-04
US60/430,651 2002-12-04
US43093702P 2002-12-05 2002-12-05
US60/430,937 2002-12-05
US43325102P 2002-12-12 2002-12-12
US60/433,251 2002-12-12
US43331602P 2002-12-13 2002-12-13
US60/433,316 2002-12-13
US43623602P 2002-12-23 2002-12-23
US60/436,236 2002-12-23
US44082103P 2003-01-17 2003-01-17
US60/440,821 2003-01-17
US46371603P 2003-04-18 2003-04-18
US46370803P 2003-04-18 2003-04-18
US60/463,708 2003-04-18
US60/463,716 2003-04-18
US46720103P 2003-05-02 2003-05-02
US46719903P 2003-05-02 2003-05-02
US60/467,201 2003-05-02
US60/467,199 2003-05-02
US47133603P 2003-05-19 2003-05-19
US60/471,336 2003-05-19
US47243003P 2003-05-22 2003-05-22
US60/472,430 2003-05-22
US47664103P 2003-06-09 2003-06-09
US47662103P 2003-06-09 2003-06-09
US60/476,641 2003-06-09
US60/476,621 2003-06-09
US48521803P 2003-07-08 2003-07-08
US48522403P 2003-07-08 2003-07-08
US48521703P 2003-07-08 2003-07-08
US60/485,218 2003-07-08
US60/485,224 2003-07-08
US60/485,217 2003-07-08
US48644603P 2003-07-14 2003-07-14
US60/486,446 2003-07-14
US48689103P 2003-07-15 2003-07-15
US60/486,891 2003-07-15
US49357703P 2003-08-08 2003-08-08
US49334103P 2003-08-08 2003-08-08
US60/493,577 2003-08-08
US60/493,341 2003-08-08

Publications (3)

Publication Number Publication Date
WO2004039952A2 WO2004039952A2 (fr) 2004-05-13
WO2004039952A8 WO2004039952A8 (fr) 2005-01-27
WO2004039952A3 true WO2004039952A3 (fr) 2009-09-11

Family

ID=32234575

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/033725 WO2004039952A2 (fr) 2002-10-25 2003-10-24 Procedes d'utilisation de polypeptides humains codes par des polynucleotides

Country Status (2)

Country Link
AU (1) AU2003294236A1 (fr)
WO (1) WO2004039952A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0817209A2 (pt) * 2007-09-20 2015-03-10 David Gladstone Inst Composições de polipeptídeo de elemento nuclear intercalado longo e métodos de uso das mesmas
US20150219662A1 (en) * 2012-06-28 2015-08-06 University Of Louisville Research Foundation, Inc. Use of protein line-1 orf-1 as a biomarker for cancer
CN113447656B (zh) * 2021-07-01 2022-05-13 浙江大学 检测抗丝状肌动蛋白成帽蛋白β-IgG抗体的试剂盒

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999022243A1 (fr) * 1997-10-24 1999-05-06 Human Genome Sciences, Inc. 148 proteines humaines secretees

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999022243A1 (fr) * 1997-10-24 1999-05-06 Human Genome Sciences, Inc. 148 proteines humaines secretees

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GENESEQ [Online] Database accession no. AAY19493 *

Also Published As

Publication number Publication date
WO2004039952A8 (fr) 2005-01-27
WO2004039952A2 (fr) 2004-05-13
AU2003294236A8 (en) 2009-10-15
AU2003294236A1 (en) 2004-05-25

Similar Documents

Publication Publication Date Title
WO2004035732A3 (fr) Polypeptides humains codes par des polynucleotides et procedes d'utilisation de ces polypeptides
WO2004020595A8 (fr) Nouveaux polypeptides humains codes par des polynucleotides
WO2004000997A3 (fr) Polypeptides therapeutiques, acides nucleiques les codant et principes d'utilisation
WO2004093804A3 (fr) Polypeptides humains codes par des polynucleotides et methodes d'utilisation associees
WO2002055705A3 (fr) Proteines et acides nucleiques codant ces proteines
WO2003033658A3 (fr) Neutrokine-alpha et variant d'epissage de neutrokine-alpha
WO2002068649A3 (fr) Proteines et acides nucleiques les codant
WO2005085280A3 (fr) Clones d'adnc humains comportant des polynucleotides et leurs procedes d'utilisation
WO2001090155A3 (fr) Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2004094651A3 (fr) Nouveaux polypeptides humains codes par des polynucleotides
WO2004099388A3 (fr) Complexes de polypeptides cbl-b et methodes associees
WO2004020591A3 (fr) Methodes d'utilisation de nouveaux polypeptides humains codes par des polynucleotides
WO2002068652A3 (fr) Proteines et acides nucleiques codant ces proteines
WO2004038003A3 (fr) Polypeptides humains codes par des polynucleotides et methodes d'utilisation
NZ524329A (en) IgE receptor antagonists that compete with IgE134 for binding to the receptor
IL207012A0 (en) Diagnosis and therapy of cancer using sgp28-related molecules
WO2003029423A3 (fr) Polypeptides therapeutiques, acides nucleiques codant ceux-ci et procedes d'utilisation
WO2004039952A3 (fr) Procedes d'utilisation de polypeptides humains codes par des polynucleotides
WO2003022998A3 (fr) Polypeptides therapeutiques, acides nucleiques codant ces derniers et methodes d'utilisation correspondantes
WO2003078572A3 (fr) Polypeptides therapeutiques, acides nucleiques codant pour ceux-ci et procedes d'utilisation
WO2003031571A3 (fr) Nouvelles proteines humaines, polynucleotides les codant et methodes d'utilisation afferentes
WO2004046310A3 (fr) Nouveaux polypeptides de souris codes par des polynucleotides et leurs procedes d'utilisation
WO2003040329A3 (fr) Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant
WO2004031354A3 (fr) Antigenes associes au sarcome humain
WO2004094598A3 (fr) Procedes d'utilisation pour de nouveaux polypeptides humains codes par des polynucleotides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 20/2004 UNDER "PUBLISHED" ADD "SEQUENCE LISTING PART OF DESCRIPTION PUBLISHED SEPARATELY IN ELECTRONIC FORM AND AVAILABLE UPON REQUEST FROM THE INTERNATIONAL BUREAU"

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP